A Study to Detect Prostate Cancer Extraprostatic Extension with Slip Interface Imaging Determined Tumor Slip Length
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 20-004250
Sponsor Protocol Number: 20-004250
About this study
The purpose of this study is to evaluate the perfomance a MR-based imaging technology (named Slip Interface Imaging) in predicting extraprostatic extension in prostate cancers.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Male adults (age ≥ 18 years old).
- Presenting to the Departments of Urology or Radiation Oncology for evaluation either for the possibility of high-risk prostate cancer, those with the tissue diagnosis who are to undergo a radical prostatectomy, or those with a rising PSA following previous treatment for prostate cancer.
- For purposes of this study, high risk is defined by, but not limited to: those patients with the worrisome level of PSA (free, total, velocity or density), digital abnormality of prostate examination, or strong family history of prostate cancer.
Exclusion Criteria:
- An absolute contraindication to MR examination.
- Urethral stricture.
- Current urinary tract infection or positive Gram stain of the urine.
- Inability to provide consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Ziying Yin, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available